Healthequity (NASDAQ:HQY) was downgraded by stock analysts at BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday.
Several other research firms have also recently weighed in on HQY. Barrington Research restated an “outperform” rating and issued a $100.00 price objective on shares of Healthequity in a research report on Wednesday, September 5th. They noted that the move was a valuation call. Cantor Fitzgerald boosted their price objective on shares of Healthequity from $80.00 to $82.00 and gave the stock a “neutral” rating in a research report on Thursday. KeyCorp boosted their price objective on shares of Healthequity from $90.00 to $105.00 and gave the stock an “overweight” rating in a research report on Tuesday, September 4th. ValuEngine cut shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Finally, Zacks Investment Research cut shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Tuesday, November 20th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $92.08.
Shares of HQY opened at $74.03 on Friday. The company has a market capitalization of $5.19 billion, a PE ratio of 137.09, a price-to-earnings-growth ratio of 2.90 and a beta of 1.37. Healthequity has a one year low of $42.92 and a one year high of $101.58.
Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 4th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.20 by $0.02. The business had revenue of $70.50 million for the quarter, compared to the consensus estimate of $69.60 million. Healthequity had a return on equity of 12.93% and a net margin of 24.52%. Healthequity’s revenue was up 24.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.17 EPS. Research analysts anticipate that Healthequity will post 0.87 earnings per share for the current fiscal year.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the company’s stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $92.93, for a total transaction of $371,720.00. Following the completion of the sale, the vice president now owns 96,100 shares in the company, valued at approximately $8,930,573. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have sold a total of 12,000 shares of company stock valued at $1,027,400 in the last quarter. Corporate insiders own 4.00% of the company’s stock.
Several institutional investors have recently modified their holdings of the business. Redwood Investments LLC bought a new stake in shares of Healthequity in the 2nd quarter valued at $12,188,000. Meeder Asset Management Inc. bought a new stake in shares of Healthequity in the 3rd quarter valued at $172,000. WINTON GROUP Ltd increased its position in shares of Healthequity by 33.7% in the 2nd quarter. WINTON GROUP Ltd now owns 4,557 shares of the company’s stock valued at $342,000 after buying an additional 1,148 shares in the last quarter. Legal & General Group Plc increased its position in shares of Healthequity by 7.7% in the 2nd quarter. Legal & General Group Plc now owns 114,642 shares of the company’s stock valued at $8,683,000 after buying an additional 8,186 shares in the last quarter. Finally, American International Group Inc. increased its position in shares of Healthequity by 249.3% in the 3rd quarter. American International Group Inc. now owns 145,055 shares of the company’s stock valued at $13,695,000 after buying an additional 103,527 shares in the last quarter. Institutional investors own 93.01% of the company’s stock.
Healthequity Company Profile
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: Dividend Stocks – Are They Right For You?